BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1561 related articles for article (PubMed ID: 26323629)

  • 21. Intestinal microbiota and ulcerative colitis.
    Ohkusa T; Koido S
    J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

  • 23. The intestinal microbiota and its role in human health and disease.
    Kataoka K
    J Med Invest; 2016; 63(1-2):27-37. PubMed ID: 27040049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.
    Vrakas S; Mountzouris KC; Michalopoulos G; Karamanolis G; Papatheodoridis G; Tzathas C; Gazouli M
    PLoS One; 2017; 12(1):e0170034. PubMed ID: 28099495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
    Nanini HF; Bernardazzi C; Castro F; de Souza HSP
    World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microbiota and inflammatory bowel disease: insights from animal models.
    Peloquin JM; Nguyen DD
    Anaerobe; 2013 Dec; 24():102-6. PubMed ID: 23603043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal Microbiota in Animal Models of Inflammatory Diseases.
    Hörmannsperger G; Schaubeck M; Haller D
    ILAR J; 2015; 56(2):179-91. PubMed ID: 26323628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonic Mucosal Microbiota and Association of Bacterial Taxa with the Expression of Host Antimicrobial Peptides in Pediatric Ulcerative Colitis.
    Jalanka J; Cheng J; Hiippala K; Ritari J; Salojärvi J; Ruuska T; Kalliomäki M; Satokari R
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gut Microbiota in Inflammatory Bowel Disease.
    Sheehan D; Shanahan F
    Gastroenterol Clin North Am; 2017 Mar; 46(1):143-154. PubMed ID: 28164847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The microbiome and inflammatory bowel disease.
    Glassner KL; Abraham BP; Quigley EMM
    J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory bowel disease: the classic gastrointestinal autoimmune disease.
    Kaistha A; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):328-34. PubMed ID: 25499459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
    Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
    Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
    Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
    Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
    World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations.
    Sheikh S; Uno J; Matsuoka K; Plevy S
    Clin Immunol; 2008 Jun; 127(3):270-9. PubMed ID: 18499066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.